Philips v. Fitbit (24-1479): Federal Circuit Appeal Dismissed After 558 Days
Philips North America asserted three patents covering wearable fitness monitoring technology against Fitbit’s Alta HR, Blaze, Charge, Inspire, Ionic, and Versa product lines. The Federal Circuit dismissed the appeal without reaching the merits, with each party bearing its own costs — a procedural resolution that leaves underlying infringement questions unanswered.
A procedural exit from a high-stakes wearables IP dispute
Philips North America, LLC filed appeal No. 24-1479 at the Court of Appeals for the Federal Circuit on 15 February 2024, challenging a prior decision in a patent infringement action against Fitbit, LLC. The dispute centred on three Philips patents — US6013007A, US8277377B2, and US7088233B2 — directed at wearable health and activity monitoring technologies, asserted against a broad portfolio of Fitbit devices including the Alta HR, Blaze, Charge 2, Charge 3, Inspire HR, Ionic, Versa, Versa 2, and Versa Lite.
The Federal Circuit granted a motion to dismiss the appeal on 26 August 2025, closing the case after 558 days with no merits adjudication. The order specifies that each party shall bear its own costs, suggesting the dismissal was not contested in a manner that would warrant cost-shifting. The basis of termination is recorded as ‘Appeal Dismissed,’ consistent with a procedural or jurisdictional resolution rather than a substantive ruling on patent validity or infringement.
A 558-day appeal timeline without a merits outcome is commercially significant: Philips’s infringement claims against the listed Fitbit wearables remain without a final appellate determination, and the three asserted patents retain their presumption of validity. The mutual cost-bearing arrangement and the procedural nature of the dismissal suggest the parties may have reached a private accommodation, though the public record is silent on any settlement terms. Competitors and product teams in the wearable fitness sector should note that these patents have not been invalidated or found not infringed at the appellate level.
Filing to Appeal Dismissed in 558 days
558 days at the Federal Circuit — longer than the median appeal resolution timeline
Appeal dismissed without merits: what the Federal Circuit order means
Procedural dismissal — no merits ruling issued
When the Federal Circuit grants a motion to dismiss an appeal, it closes the case without evaluating whether the lower court’s decision was correct. This means no appellate ruling on patent validity, claim construction, or infringement has been issued. The dismissal is procedural or jurisdictional in nature — the court did not reach the substance of Philips’s arguments against Fitbit.
No substantive adjudicationPhilips’s patents survive — unenforced but unchallenged at this level
A dismissed appeal does not invalidate the asserted patents. US6013007A, US8277377B2, and US7088233B2 retain their presumption of validity. However, Philips did not secure an infringement finding or injunctive relief against Fitbit’s wearable lines through this proceeding. The dismissal effectively resets enforcement risk without resolving it — future litigation or licensing pressure remains a strategic option for Philips.
Patents valid, claims unresolvedFitbit avoids an adverse merits ruling — for now
Fitbit exits this appeal without a finding of infringement and without the three Philips patents being enforced against its wearable product lines at the appellate level. The cost-neutral order avoids financial penalty. However, because no merits decision was issued, Fitbit cannot rely on this dismissal as a precedential shield against future infringement assertions based on the same patents — the underlying exposure is not extinguished.
No infringement finding; no safe harbourUnresolved patent risk persists across the wearables sector
The procedural exit leaves three health monitoring patents in active status without a merits disposition. Competitors designing wearables with heart rate, activity tracking, or biometric monitoring features should treat these Philips patents as live enforcement risk. The absence of an invalidity ruling or non-infringement determination means design-around analysis and FTO clearance remain prudent for any product operating in adjacent technology space.
Active FTO risk for wearablesFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Philips North America, LLC | Company | Consumer health technology IP licensor — holder of US6013007A, US8277377B2, and US7088233B2Search in Eureka ↗ |
| Defendant | Fitbit, LLC | Company | Fitbit, LLC — Google-owned wearable fitness tracker manufacturer, multiple product lines accusedSearch in Eureka ↗ |
| Plaintiff counsel | Eley Thompson | Attorney | Counsel for Philips North America, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Ruben Jose Rodrigues | Attorney | Counsel for Philips North America, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Sarah E. Rieger | Attorney | Counsel for Philips North America, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Foley & Lardner, LLP | Law Firm | Representing Philips North America, LLCSearch in Eureka ↗ |
| Defendant counsel | Adam Steinmetz | Attorney | Counsel for Fitbit, LLCSearch in Eureka ↗ |
| Defendant counsel | David James Shaw | Attorney | Counsel for Fitbit, LLCSearch in Eureka ↗ |
| Defendant counsel | John M. Desmarais | Attorney | Counsel for Fitbit, LLCSearch in Eureka ↗ |
| Defendant counsel | Justin P.D. Wilcox | Attorney | Counsel for Fitbit, LLCSearch in Eureka ↗ |
| Defendant counsel | Rebecca Lindhorst | Attorney | Counsel for Fitbit, LLCSearch in Eureka ↗ |
| Defendant law firm | Desmarais LLP | Law Firm | Representing Fitbit, LLCSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
Official order — verbatim text
The Federal Circuit’s order is succinct and procedural: the motion to dismiss is granted and the appeal is closed, with costs neutralised between the parties. The absence of any merits language — no discussion of claim construction, obviousness, or infringement — confirms this is a jurisdictional or agreed dismissal rather than a substantive ruling. The cost-neutrality clause is notable; appellate courts typically award costs to the prevailing party under Fed. R. App. P. 39, making a mutual cost-bearing order consistent with a stipulated or negotiated dismissal. Neither party can cite this order as dispositive on the patent merits.
US6013007A, US8277377B2 & US7088233B2 — Philips wearable health monitoring patents
The three patents asserted by Philips cover a range of wearable health monitoring technologies. US6013007A, filed under application US09/048214, is among the earlier filings and likely covers foundational wearable activity monitoring architectures. US8277377B2 (application US12/211033) and US7088233B2 (application US10/165624) extend into physiological sensing and data transmission in body-worn devices — technology directly relevant to modern fitness trackers incorporating heart rate, motion, and biometric sensing.
These patents sit at the centre of the wearable fitness IP landscape, covering technology embedded in mainstream consumer devices. Philips’s willingness to assert all three in a single infringement action against Fitbit’s full product range — nine named SKUs — signals a broad licensing posture rather than targeted product-specific enforcement. For competitors in the smartwatch and fitness band market, these patents represent a cluster of foundational claims that have not been adjudicated invalid, making design-around analysis and prior art mapping essential steps for any new product development in this space.
Should you run an FTO against US6013007A, US8277377B2 & US7088233B2?
Any R&D team developing wearable devices with heart rate monitoring, activity tracking, or biometric data collection should treat these three Philips patents as active clearance requirements. The Federal Circuit dismissal in 24-1479 does not constitute a non-infringement or invalidity determination — the patents are in force and have been actively asserted against a wide range of commercial wearables. Product categories at risk include smartwatches, fitness bands, medical-grade wearables, and any IoT device incorporating body-worn sensing.
PatSnap Eureka’s FTO Search Agent can map your product’s feature set against the claim scope of all three Philips patents, surface relevant prior art that may support invalidity arguments, and flag design-around opportunities before product launch. With no appellate merits ruling to rely on, proactive FTO clearance is the most defensible path for wearable hardware and software teams operating near this patent cluster.
Run a freedom-to-operate analysis on US6013007A to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit wearable health technology patent appeals
Federal Circuit cases involving wearable health monitoring patents and fitness tracker infringement claims, comparable to Philips v. Fitbit (24-1479).
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Fitbit Alta HR-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedPhilips North America, LLC’s broader IP enforcement history
Philips North America, LLC’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the wearable health technology IP landscape
A procedural Federal Circuit dismissal with no cost-shifting often signals behind-the-scenes resolution — but leaves IP risk open for the broader market.
Procedural exits at the Federal Circuit rarely extinguish patent risk
When an appeal is dismissed on procedural grounds, the asserted patents are not invalidated and no non-infringement ruling issues. For wearable fitness device makers, this means Philips’s three patents — covering activity and health monitoring — remain enforceable. Teams building in this space should not interpret the dismissal as IP clearance.
Mutual cost-bearing is a soft signal of negotiated resolution
Federal Circuit orders directing each party to bear its own costs, paired with a motion-granted dismissal, are consistent with a settlement or licensing agreement reached after appeal was filed. While the public record confirms no terms, this pattern typically signals that commercial resolution was reached privately rather than through judicial determination.
Three Philips patents remain active — licensing strategy likely continues
With no invalidity or non-infringement ruling, Philips retains full enforcement leverage on US6013007A, US8277377B2, and US7088233B2 against any wearable health monitoring product. A dismissed appeal with unresolved claims is a known precursor to renewed licensing campaigns targeting adjacent competitors in the fitness tracker and smartwatch market.
Fitbit product lines named — successor Google Pixel Watch exposure warrants monitoring
The accused Fitbit products span a wide generation range. Given Google’s acquisition of Fitbit and integration into the Pixel Watch line, IP counsel at Google and competing wearable OEMs should assess whether the patent claims in this dispute extend to current-generation heart rate and activity monitoring implementations — particularly under claim scope that survived appellate challenge.
Philips v Fitbit — key questions answered
The Federal Circuit dismissed Philips’s appeal in Case 24-1479 on 26 August 2025, after 558 days, without issuing a merits ruling. The court granted a motion to dismiss and ordered each party to bear its own costs. No finding of infringement or invalidity was made regarding the three asserted Philips patents covering wearable health monitoring technology.
Philips asserted three patents: US6013007A (application US09/048214), US8277377B2 (application US12/211033), and US7088233B2 (application US10/165624). All three relate to wearable health and activity monitoring technology and were asserted against nine named Fitbit product lines including the Alta HR, Blaze, Charge 2, Charge 3, Inspire HR, Ionic, Versa, Versa 2, and Versa Lite.
No. A procedural dismissal does not affect patent validity. US6013007A, US8277377B2, and US7088233B2 retain their presumption of validity under 35 U.S.C. § 282. The Federal Circuit did not evaluate claim construction, obviousness, or infringement. The patents remain enforceable assets in Philips’s portfolio.
Under Federal Rule of Appellate Procedure 39, costs are typically awarded to the prevailing party. A mutual cost-bearing order — where neither party recovers costs — is consistent with a stipulated or negotiated dismissal, suggesting the parties may have reached a private agreement. The public record does not disclose any settlement terms.
Nine Fitbit products were named: the Alta HR, Blaze, Charge 2, Charge 3, Inspire HR, Ionic, Versa, Versa 2, and Versa Lite. These span Fitbit’s mainstream fitness tracker and smartwatch lines across multiple product generations, indicating Philips pursued broad portfolio-level enforcement rather than a targeted product claim.
Track wearable health patent risk before your next product launch
The Philips patents asserted in this case remain in force with no invalidity ruling. Run an FTO search against US6013007A, US8277377B2, and US7088233B2 in PatSnap Eureka — and set enforcement monitoring alerts before your next wearable device goes to market.
PatSnap Eureka searches patents and litigation data to answer instantly.